Literature DB >> 19775727

Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.

Hiroko Noguchi1, Tomoko Mitsuhashi, Kunihiko Seki, Naofumi Tochigi, Masahisa Tsuji, Tadakazu Shimoda, Tadashi Hasegawa.   

Abstract

Extraskeletal myxoid chondrosarcomas (EMCs) are characterized histologically by a cord-like or lace-like arrangement of small round cells or short spindle cells with eosinophilic cytoplasm distributed in a rich myxoid matrix. Atypical cases of EMC have also been described, with areas of poor mucus production and high cellularity and a transition to typical EMC. Most cases of EMC harbor the chromosomal reciprocal translocation t(9;22) (q22;q12) and the resultant fused gene, Ewing sarcoma region 1-nuclear receptor subfamily 4, group A, member 3 (EWSR1-NR4A3). Other translocations, such as those involving the NR4A3 gene, have also been noted, although these occur at a lower frequency. On this basis, we conducted a fluorescence in situ hybridization (FISH) analysis of 18 cases of EMC in which patients presented with typical or atypical (areas of high cellularity) histologic features of EMC. We used an EWSR1 probe and a newly prepared NR4A3 probe to evaluate the usefulness of FISH in the pathologic diagnosis of EMC. FISH analysis using the EWSR1 or NR4A3 probe showed split signals in 83% (15/18) of the cases, regardless of the presence of typical/atypical histologic features. Gene rearrangement of EWSR1 was noted in 72% (13/18) of the cases, and rearrangement of NR4A3 was noted in 61% (11/18) of the cases. The NR4A3 rearrangement was detected in 2 cases not carrying any EWSR1 rearrangement, as determined by reverse transcription-polymerase chain reaction. These results suggest that FISH analysis of formalin-fixed, paraffin-embedded specimens using EWSR1 and NR4A3 probes is useful and convenient and may provide an ancillary method for the diagnosis of EMC. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775727     DOI: 10.1016/j.humpath.2009.04.028

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.

Authors:  Akihiko Yoshida; Naohiro Makise; Susumu Wakai; Akira Kawai; Nobuyoshi Hiraoka
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

2.  Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.

Authors:  Anna Paioli; Silvia Stacchiotti; Domenico Campanacci; Emanuela Palmerini; Anna Maria Frezza; Alessandra Longhi; Stefano Radaelli; Davide Maria Donati; Giovanni Beltrami; Giuseppe Bianchi; Marta Barisella; Alberto Righi; Stefania Benini; Marco Fiore; Piero Picci; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2020-06-22       Impact factor: 5.344

3.  Histopathological, immunohistochemical and molecular spectrum of myoepithelial tumours of soft tissues.

Authors:  Bharat Rekhi; Mukund Sable; Nirmala A Jambhekar
Journal:  Virchows Arch       Date:  2012-10-25       Impact factor: 4.064

4.  Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.

Authors:  Narasimhan P Agaram; Lei Zhang; Yun-Shao Sung; Samuel Singer; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2014-01-28       Impact factor: 3.466

5.  Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE).

Authors:  Megumi Hirobe; Naoya Masumori; Toshiaki Tanaka; Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

Review 6.  Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).

Authors:  Margherita Cerrone; Monica Cantile; Francesca Collina; Laura Marra; Giuseppina Liguori; Renato Franco; Annarosaria De Chiara; Gerardo Botti
Journal:  Int J Mol Med       Date:  2014-04-04       Impact factor: 4.101

7.  Myxoid chondrosarcoma of sphenoid bone.

Authors:  Amit K Chowhan; Nandyala Rukmangadha; Rashmi Patnayak; Chandra Mouliswara Prasad Bodapati; Vijaya Laxmi Bodagala; Mandyam Kumaraswamy Reddy
Journal:  J Neurosci Rural Pract       Date:  2012-09

8.  NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma.

Authors:  Uta Flucke; Bastiaan B J Tops; Marian A J Verdijk; Patricia J H van Cleef; Peter H van Zwam; Pieter J Slootweg; Judith V M G Bovée; Robert G Riedl; David H Creytens; Albert J H Suurmeijer; Thomas Mentzel
Journal:  Virchows Arch       Date:  2012-05-09       Impact factor: 4.064

9.  Primary extraskeletal myxoid chondrosarcoma in cerebellum: A case report with literature review.

Authors:  You Qin; Hai-Bo Zhang; Chang-Shu Ke; Jing Huang; Bian Wu; Chao Wan; Chen-Su Yang; Kun-Yu Yang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

10.  Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.

Authors:  Sho Egashira; Masatoshi Jinnin; Manami Ajino; Naoki Shimozono; Sayo Okamoto; Yukino Tasaki; Ayaka Hirano; Maho Ide; Ikko Kajihara; Jun Aoi; Miho Harada; Toshikatsu Igata; Shinichi Masuguchi; Satoshi Fukushima; Hironobu Ihn
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.